Patient related factors are also important in treating gout

BMJ (Online)

Volumn 344, Issue 7839, 2012, Pages

  Chandratre, Priyanka ^a   Roddy, Edward ^a   Mallen, Christian ^a  

^a KEELE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGOUT AGENT; COLCHICINE; NONSTEROID ANTIINFLAMMATORY AGENT; UNCLASSIFIED DRUG; URATE LOWERING DRUG;

CARDIOVASCULAR RISK; CONSULTATION; DOCTOR PATIENT RELATION; DRUG SAFETY; DRUG USE; GOUT; HEALTH CARE ACCESS; HIGH RISK PATIENT; HUMAN; INAPPROPRIATE PRESCRIBING; JOINT INJURY; LETTER; LIFESTYLE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT EDUCATION; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RECURRENT DISEASE; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; CLINICAL PRACTICE; NOTE; PRACTICE GUIDELINE; STANDARD;

GOUT; GOUT SUPPRESSANTS; GUIDELINE ADHERENCE; HUMANS; PHYSICIAN'S PRACTICE PATTERNS;

EID: 84860570678     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.e191     Document Type: Letter

References (5)

1. Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Schumacher HR Jr, Saag KG. Gout epidemiology: results from the UK general practice research database, 1990-1999. Ann Rheum Dis 2005;64:267-72. (Pubitemid 40197509)
2. Lipworth W, Kerridge I, Brett J, Day R. How clinical and research failures lead to suboptimal prescribing: the example of chronic gout. BMJ 2011;343:d7459. (1 December.)
3. Jordan KM, Cameron JS, Snaith M, Zhang W, Doherty M, Seckl J, et al. British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout. Rheumatology 2007;46:1372-4.
4. Lindsay K, Gow P, Vanderpyl J, Logo P, Dalbeth N. The experience and impact of living with gout: A study of men with chronic gout using a qualitative grounded theory approach. J Clin Rheumatol 2011;17:1-6.
5. Roddy E, Doherty M. Epidemiology of gout. Arthritis Res Ther 2010;12:223.